BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 19145239)

  • 1. Clinical and epidemiological assessment of steroid-resistant nephrotic syndrome associated with the NPHS2 R229Q variant.
    Machuca E; Hummel A; Nevo F; Dantal J; Martinez F; Al-Sabban E; Baudouin V; Abel L; Grünfeld JP; Antignac C
    Kidney Int; 2009 Apr; 75(7):727-35. PubMed ID: 19145239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of NPHS2 analysis in early- and adult-onset steroid-resistant nephrotic syndrome.
    Santín S; Tazón-Vega B; Silva I; Cobo MÁ; Giménez I; Ruíz P; García-Maset R; Ballarín J; Torra R; Ars E;
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):344-54. PubMed ID: 20947785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [NPHS2 Mutation analysis study in children with steroid-resistant nephrotic syndrome].
    Azocar M; Vega Á; Farfán M; Cano F
    Rev Chil Pediatr; 2016; 87(1):31-6. PubMed ID: 26455708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A spectrum of novel NPHS1 and NPHS2 gene mutations in pediatric nephrotic syndrome patients from Pakistan.
    Abid A; Khaliq S; Shahid S; Lanewala A; Mubarak M; Hashmi S; Kazi J; Masood T; Hafeez F; Naqvi SA; Rizvi SA; Mehdi SQ
    Gene; 2012 Jul; 502(2):133-7. PubMed ID: 22565185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R229Q polymorphism of NPHS2 gene in patients with late-onset steroid-resistance nephrotic syndrome: a preliminary study.
    Fotouhi N; Ardalan M; Jabbarpour Bonyadi M; Abdolmohammadi R; Kamalifar A; Nasri H; Einollahi B
    Iran J Kidney Dis; 2013 Sep; 7(5):399-403. PubMed ID: 24072153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel NPHS2 variant in patients with familial steroid-resistant nephrotic syndrome with early onset, slow progression and dominant inheritance pattern.
    Suvanto M; Patrakka J; Jahnukainen T; Sjöström PM; Nuutinen M; Arikoski P; Kataja J; Kestilä M; Jalanko H
    Clin Exp Nephrol; 2017 Aug; 21(4):677-684. PubMed ID: 27573339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence.
    Weber S; Gribouval O; Esquivel EL; Morinière V; Tête MJ; Legendre C; Niaudet P; Antignac C
    Kidney Int; 2004 Aug; 66(2):571-9. PubMed ID: 15253708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NPHS2 p.V290M mutation in late-onset steroid-resistant nephrotic syndrome.
    Kerti A; Csohány R; Szabó A; Arkossy O; Sallay P; Moriniére V; Vega-Warner V; Nyírő G; Lakatos O; Szabó T; Lipska BS; Schaefer F; Antignac C; Reusz G; Tulassay T; Tory K
    Pediatr Nephrol; 2013 May; 28(5):751-7. PubMed ID: 23242530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotic Syndrome With Mutations in NPHS2: The Role of R229Q and Implications for Genetic Counseling.
    Rood IM; Deegens JKJ; Lugtenberg D; Bongers EMHF; Wetzels JFM
    Am J Kidney Dis; 2019 Mar; 73(3):400-403. PubMed ID: 30241959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heterozygotic mutation in NPHS2 gene as a cause of familial steroid resistant nephrotic syndrome in two siblings--case report].
    Drozdz D; Pietrzyk JA; Wierzchowska-Słowiaczek E; Sancewicz-Pach K; Antignac C; Miezyński W
    Przegl Lek; 2006; 63 Suppl 3():85-6. PubMed ID: 16898497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele.
    Tsukaguchi H; Sudhakar A; Le TC; Nguyen T; Yao J; Schwimmer JA; Schachter AD; Poch E; Abreu PF; Appel GB; Pereira AB; Kalluri R; Pollak MR
    J Clin Invest; 2002 Dec; 110(11):1659-66. PubMed ID: 12464671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide variations in the NPHS2 gene in Greek children with steroid-resistant nephrotic syndrome.
    Megremis S; Mitsioni A; Mitsioni AG; Fylaktou I; Kitsiou-Tzelli S; Stefanidis CJ; Kanavakis E; Traeger-Synodinos J
    Genet Test Mol Biomarkers; 2009 Apr; 13(2):249-56. PubMed ID: 19371226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WT1 and NPHS2 gene mutation analysis and clinical management of steroid-resistant nephrotic syndrome.
    Ramanathan AS; Vijayan M; Rajagopal S; Rajendiran P; Senguttuvan P
    Mol Cell Biochem; 2017 Feb; 426(1-2):177-181. PubMed ID: 27885584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic screening in adolescents with steroid-resistant nephrotic syndrome.
    Lipska BS; Iatropoulos P; Maranta R; Caridi G; Ozaltin F; Anarat A; Balat A; Gellermann J; Trautmann A; Erdogan O; Saeed B; Emre S; Bogdanovic R; Azocar M; Balasz-Chmielewska I; Benetti E; Caliskan S; Mir S; Melk A; Ertan P; Baskin E; Jardim H; Davitaia T; Wasilewska A; Drozdz D; Szczepanska M; Jankauskiene A; Higuita LM; Ardissino G; Ozkaya O; Kuzma-Mroczkowska E; Soylemezoglu O; Ranchin B; Medynska A; Tkaczyk M; Peco-Antic A; Akil I; Jarmolinski T; Firszt-Adamczyk A; Dusek J; Simonetti GD; Gok F; Gheissari A; Emma F; Krmar RT; Fischbach M; Printza N; Simkova E; Mele C; Ghiggeri GM; Schaefer F;
    Kidney Int; 2013 Jul; 84(1):206-13. PubMed ID: 23515051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.
    Ruf RG; Lichtenberger A; Karle SM; Haas JP; Anacleto FE; Schultheiss M; Zalewski I; Imm A; Ruf EM; Mucha B; Bagga A; Neuhaus T; Fuchshuber A; Bakkaloglu A; Hildebrandt F;
    J Am Soc Nephrol; 2004 Mar; 15(3):722-32. PubMed ID: 14978175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2).
    Hinkes BG; Mucha B; Vlangos CN; Gbadegesin R; Liu J; Hasselbacher K; Hangan D; Ozaltin F; Zenker M; Hildebrandt F;
    Pediatrics; 2007 Apr; 119(4):e907-19. PubMed ID: 17371932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broadening the spectrum of diseases related to podocin mutations.
    Caridi G; Bertelli R; Di Duca M; Dagnino M; Emma F; Onetti Muda A; Scolari F; Miglietti N; Mazzucco G; Murer L; Carrea A; Massella L; Rizzoni G; Perfumo F; Ghiggeri GM
    J Am Soc Nephrol; 2003 May; 14(5):1278-86. PubMed ID: 12707396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NPHS2 R229Q polymorphism in steroid resistant nephrotic syndrome: is it responsive to immunosuppressive therapy?
    Mishra OP; Kakani N; Singh AK; Narayan G; Abhinay A; Prasad R; Batra VV
    J Trop Pediatr; 2014 Jun; 60(3):231-7. PubMed ID: 24519673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific podocin mutations determine age of onset of nephrotic syndrome all the way into adult life.
    Hildebrandt F; Heeringa SF
    Kidney Int; 2009 Apr; 75(7):669-71. PubMed ID: 19282856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causal and putative pathogenic mutations identified in 39% of children with primary steroid-resistant nephrotic syndrome in South Africa.
    Nandlal L; Winkler CA; Bhimma R; Cho S; Nelson GW; Haripershad S; Naicker T
    Eur J Pediatr; 2022 Oct; 181(10):3595-3606. PubMed ID: 35920919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.